WEBSITECHANGES

Website Changes

---

04/14/2025

VMX01 Plus Avelumab Is Safe and Shows Preliminary Clinical Activity in Recurrent Glioblastoma

---

04/11/2025

Musella Foundation Copay Program now closed to new and renewal applicants

---

04/11/2025

Promising Preliminary Results of Phase 1 Study

---

04/01/2025

Copayment assistance program is now open!

---

03/31/2025

UT Health San Antonio-led research discovers a way to slow or block recurrence in glioblastoma

---

03/31/2025

Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields

---

03/30/2025

Cancer Commons: Breaking Barriers in Cancer Care

---

03/17/2025

Hoops for Hannah: a March Madness Bracket Contest!

---

03/17/2025

Repurposed Cancer Drug Demonstrates Potential to Treat High-Grade Gliomas

---

03/17/2025

Studying Chemical Exposure and Brain Cancer Risk in Firefighters

---

03/17/2025

LAM561 as add-on may delay glioblastoma disease progression

---

03/10/2025

Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma

---

03/10/2025

Webinar tomorrow: The Gallium Maltolate Expanded Access Program: A Physician`s & Caregiver`s Perspective

---

03/03/2025

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma

---

02/27/2025

Treatment strategy reprograms brain cancer cells, halting tumor growth

---

02/24/2025

Hydrogel and scalp/skin conductivities impact dose from tumor treating fields

---

02/12/2025

Musella Foundation Brain Tumor Treatment Copayment Assistance Program is now closed to new patients

---

02/10/2025

Targepeutics Receives Rare Pediatric Disease Designation from FDA for GB13

---

02/05/2025

Curtana Pharmaceuticals Announces Breakthrough in Pediatric Brain Cancer Treatment with Dual Studies Published in Nature Communications

---

02/04/2025

College Scholarship for Brain and Spinal Cord Tumor Survivors Now Open

---

01/27/2025

Recent Imaging Biometrics webinar on Oral Gallium Maltolate

---

01/27/2025

Musella Foundation Copayment Assistance Program Closing Soon

---

01/27/2025

Webinar Tomorrow: Using ultrasound technology to open the blood-brain barrier

---

01/20/2025

Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?

---

01/20/2025

Upcoming Webinar: Using ultrasound technology to open the blood-brain barrier

---